CASI Pharmaceuticals
CASI
#9475
Rank
HK$0.34 B
Marketcap
HK$22.22
Share price
-5.30%
Change (1 day)
-57.83%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2022 (TTM): -HK$23.32

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$23.16. In 2021 the company made an earnings per share (EPS) of -HK$21.14 an increase over its 2020 EPS that were of -HK$33.96.

EPS history for CASI Pharmaceuticals from 1996 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-HK$23.3210.35%
2021-HK$21.14-37.76%
2020-HK$33.96-8.96%
2019-HK$37.3050%
2018-HK$24.8777.78%
2017-HK$13.99-7.42%
2016-HK$15.11-11.63%
2015-HK$17.10-75.56%
2014-HK$69.93309.09%
2013-HK$17.10-72.84%
2012-HK$62.9468.75%
2011-HK$37.30-48.94%
2010-HK$73.04-19.66%
2009-HK$90.91-62.01%
2008-HK$239.33-0%
2007-HK$239.33-62.67%
2006-HK$641.07134.38%
2005-HK$273.52-13.51%
2004-HK$316.26-44.78%
2003-HK$572.69-62.36%
2002-HK$1,521-26.14%
2001-HK$2,060-20.72%
2000-HK$2,59813.43%
1999-HK$2,291150.47%
1998-HK$914.5994.55%
1997-HK$470.1227.91%
1996-HK$367.55